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Results 
Conclusion 
Methods 
 
Background 
  
• Chagas disease is a chronic, 
systemic condition endemic in 
Central and South America.  
• One common manifestation of this 
parasitic infection, Chagas heart 
disease (ChD), is an 
underdiagnosed entity with serious 
clinical implications. 
• Data are limited regarding the 
demographics and clinical aspects 
of this disease in the United States. 
 
• Using the U.S. Nationwide 
Inpatient Sample databases 2003 
through 2012 and appropriate ICD-
9 codes, we identified 
hospitalizations in patients ≥ 18 
years of age with a primary or 
secondary diagnosis of Chagas 
disease and ChD.  
• Cases with missing data and other 
cardiomyopathies were excluded 
for analysis purposes. 
• Demographics and various cardiac 
conditions were then analyzed 
using appropriate ICD-9 codes. 
Results 
• Of the 1,577 hospitalizations with a diagnosis of Chagas 
disease, 1050 (66.6%) had diagnosed CHD (mean age 
57±15 years, 50.0% women, 74.1% Hispanic).  
• The largest numbers CHD cases were seen in California 
(33%), followed by Florida (14%) and New York (10%). 
• Congestive heart failure (CHF) (28%) was the most 
common primary discharge diagnosis, followed by 
dysrhythmias (9.4%).  
 
• Hospitalization with a recognized 
diagnosis of CHD is uncommon in the 
US.  
• Patients hospitalized with CHD are 
generally young and demonstrate 
severe cardiac disease, including a 
very high burden of CHF and 
arrhythmias from underlying chronic 
myocarditis. 
• The rates of device implantation are 
high in CHD population.  
• CHD is associated with substantial 
hospitalization costs. 
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• In patients with CHD, CHF was present 
in 63%, arrhythmias in 58.5%, 
conduction abnormalities in 12.2%, 
and cardiac devices in 41.2% (Figure).  
• Median length of stay was 5 days, median 
hospitalization charges were US$ 33,591, 
and all-cause inpatient mortality was 
3.3%. 
 
Myocardial/Pump abnormalities 
        1) Congestive heart failure 
        2) Dilated cardiomyopathy 
        3) Ventricular aneurysm  
  
62.5% 
43.9% 
3.8% 
Arrhythmias/ Conduction abnormality 
        1) Atrial fibrillation 
        2) Ventricular tachycardia 
        3) Sinus node dysfunction 
        4) Bundle branch Block 
        5) Complete heart Block 
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Cardiac Devices 
         1) Pacemaker 
         2) Implanted cardioverter      
             defibrillator 
41.2% 
16.8% 
28.7% 
